Table 3.

Differences in 30-Day Outcomes Between PWH and Non-HIV-Infected COVID-19 Patients

Outcomes	Before Matching				After Matching
	HIV	Non-HIV	OR (95% CI)	P Value	HIV	Non-HIV	OR (95% CI)	P Value
Hospitalization	270 (16.5%)	22 398 (7.6%)	2.41 (2.11–2.74)	<.001	269 (16.5%)	218 (13.5%)	1.26 (1.04–1.53)	.023
Intensive care services	68 (4.2%)	6731 (2.3%)	1.86 (1.45–2.36)	<.001	68 (4.2%)	71 (4.4%)	0.94 (0.67–1.32)	.790
Ventilation management	40 (2.4%)	4624 (1.6%)	1.58 (1.13–2.14)	.005	40 (2.4%)	46 (2.9%)	0.85 (0.55–1.31)	.536
Mortality at 30 days	47 (2.9%)	6708 (2.3%)	1.28 (0.94–1.69)	.1233	46 (2.8%)	61 (3.8%)	0.74 (0.50–1.08)	.145

Bold indicates statistically significant values.

Abbreviations: COVID-19, coronavirus disease 2019; CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio; PWH, people with HIV.

^aResults shown both before and after propensity score matching.